|
|
|
|
 
Institute of Medicine
500 Fifth Street NW
Washington DC 20001
iomwww@nas.edu
tel: 202.334.2352
fax: 202.334.1412
Media Contact
(Journalists Only)
news@nas.edu
tel. 202.334.2138
fax: 202.334.2158
Staff Directory
|
|
|
|
|
|
|
|
|
|
Cohort R62: Epidemiological Studies of Cancer
|
|
|
Title: Cohort R62: Epidemiological Studies of Cancer
Summary: Following the start up of the Veterans Administration's Beneficiary Identification and Records Locator System (BIRLS), a multi-faceted project was performed to study the mortality of several conditions: alcoholism, asthma, splenectomy, nephrectomy, and orchiopexy. All groups were selected from Army hospital admission files for the years 1944 and 1945. Controls were matched on overseas vs. U.S. admissions, battle vs. non-battle casualty, trauma vs. disease, age, race, and rank (officer or enlisted) at time of admission.
References:
Robinette C.D. and Fraumeni J.F. Asthma and subsequent mortality in World War II veterans. J Chronic Dis 31:619-624, 1978.
Robinette C.D. and Fraumeni J.F. Splenectomy and subsequent mortality in veterans of the 1939-1945 war. Lancet 2(8029):127-129, 1977.
Robinette C.D., Hrubec Z., and Fraumeni J.F. Chronic alcoholism and subsequent mortality in World War II veterans. Am J Epidemiol 109:687-700, 1979.
Keywords: cancer; carcinoma; splenectomy; bronchial asthma; alcoholism; nephrectomy; orchiopexy; immunity; testicular cancer
Cohort Characteristics: 34,388 total records
*EAD=date of entry into active duty. *RAD=date of release from active duty
|
Data item |
Alcohol
(n=5,042) |
Resp Cond
(n=13,105) |
Splenect
(n=892) |
Nephrect
(n=1245) |
Orchio
(n=194) |
Comp
(n=13,910) |
|
MSN: |
100% |
100% |
100% |
100% |
100% |
100% |
|
SSN: |
15% |
40% |
60% |
60% |
27% |
28% |
|
Claim #: |
75% |
91% |
92% |
91% |
81% |
80% |
|
Name: |
99% |
99% |
99% |
98% |
99% |
99% |
|
Race: |
100% |
100% |
100% |
100% |
100% |
100% |
|
White: |
89% |
85% |
98% |
94% |
95% |
86% |
|
DOB: |
14% |
29% |
41% |
41% |
25% |
22% |
|
DOD: |
36% |
26% |
20% |
24% |
13% |
16% |
|
UCOD: |
98% |
95% |
95% |
96% |
84% |
95% |
|
EAD*: |
35% |
61% |
88% |
86% |
31% |
30% |
|
RAD*: |
35% |
61% |
88% |
86% |
31% |
30% |
|
Rank: |
100% |
100% |
100% |
100% |
100% |
100% |
|
Branch: |
100% |
100% |
100% |
100% |
100% |
100% |
|
Cancer: |
4.3% |
3.9% |
2.5% |
4.1% |
3.6% |
2.6% |
|
|
|
|
|
|
Last Updated: 8/15/2005, 01:48 PM
|
|
|
|
|
|
|
|